Revolutionary Antiviral Strategy: Disrupting Viruses' Defenses

Chemists are developing experimental antiviral drugs that target the fatty membranes protecting viruses, including those causing COVID-19 and the flu. By destroying these membranes, the drugs render the viruses vulnerable and unable to enter cells. This new strategy offers hope for a wide range of pathogens, as the membranes are less likely to develop resistance compared to viral proteins, which are the usual targets of antiviral drugs.